Chao He

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Transcription Factor

Endothelial Cells

Top Venues

Canadian journal of gastroenterology & hepatology

This page only lists publications with an associated author ORCID identifier.

Publications

Bo Shu, Yingxia Zhou, Guoqiong Lei, Yu Peng, Cong Ding, Zhuan Li, Chao He
TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway. Cancer science 115 (5) (2024)
Bo Shu, Yingxia Zhou, Guoqiong Lei, Yu Peng, Cong Ding, Zhuan Li, Chao He
TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway. Cancer science 115 (5) (2024)
Bo Shu, Yingxia Zhou, Guoqiong Lei, Yu Peng, Cong Ding, Zhuan Li, Chao He
TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway. Cancer science 115 (5) (2024)
Bo Shu, Yingxia Zhou, Guoqiong Lei, Yu Peng, Cong Ding, Zhuan Li, Chao He
TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway. Cancer science (2024)
Bo Shu, Yingxia Zhou, Guoqiong Lei, Yu Peng, Cong Ding, Zhuan Li, Chao He
TRIM21 is critical in regulating hepatocellular carcinoma growth and response to therapy by altering the MST1/YAP pathway. Cancer science 115 (5) (2024)
Guoqiong Lei, Sushun Liu, Xin Yang, Chao He
TRIM29 Reverses Oxaliplatin Resistance of P53 Mutant Colon Cancer Cell. Canadian journal of gastroenterology & hepatology 2021 (2021)